Corrigendum to “nivolumab Plus Ipilimumab in Melanoma Patients with Asymptomatic Brain Metastases: 7-Year Outcomes and Quality of Life from the Multicenter Phase III NIBIT-M2 Trial” [eur J Cancer 199 (2024) 113531]

EUROPEAN JOURNAL OF CANCER(2024)

引用 0|浏览34
暂无评分
关键词
Brain Metastases
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要